Cargando…
Recurrent Metastatic Choriocarcinoma Responsive to Etoposide and Cisplatin with Etoposide, Methotrexate, and Dactinomycin: A Case Report
Choriocarcinoma is a malignant trophoblastic tumour usually of placental origin. It is characterized by early metastasis to the brain and lungs. With early detection, it has a better prognosis with treatment. We report a case of 18 years female at 26 weeks of gestation in her third pregnancy who had...
Autores principales: | Das, Sunil Kumar, Shahi, Arun, Panthi, Ram Chandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Journal of the Nepal Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252234/ https://www.ncbi.nlm.nih.gov/pubmed/35633247 http://dx.doi.org/10.31729/jnma.7081 |
Ejemplares similares
-
Persistent gestational trophoblastic disease: results of MEA (methotrexate, etoposide and dactinomycin) as first-line chemotherapy in high risk disease and EA (etoposide and dactinomycin) as second-line therapy for low risk disease
por: Dobson, L S, et al.
Publicado: (2000) -
Hypersensitivity to Etoposide in Case of Metastatic Gestational Choriocarcinoma
por: Lazović, Biljana, et al.
Publicado: (2013) -
Refractory Choriocarcinoma: Complete Response With Oral Etoposide
por: Dhanushkodi, Manikandan, et al.
Publicado: (2016) -
Serum human chorionic gonadotropin ratios for the detection of etoposide, methotrexate, dactinomycin, cyclophosphamide, and vincristine resistance in high‐risk gestational trophoblastic neoplasia
por: Sirimusika, Nathapol, et al.
Publicado: (2022) -
Outcome of treatment with EMA/EP (etoposide methotrexate and actinomycin-D/ etoposide and cisplatin) regimen in gestational trophoblastic neoplasia
por: Aminimoghaddam, Soheila, et al.
Publicado: (2018)